-
to groundbreaking projects, employing high-throughput CRISPR genetic screening to unveil novel targets and utilizing single-cell technology for in-depth genome analysis in hematological malignancies. You will also
-
immune checkpoints and ligands on various hematopoietic malignant and solider tumor cells with high-throughput screening and protein engineering approaches developed in the lab, and develop novel cancer
-
Mathematics, Statistics, Physics, Computer Science, Engineering or related discipline Experience with genome sequencing data (ex. DNA, RNA, ATAC seq) Experience with stochastic dynamical systems and probability
-
experience) is available in the Cellular Therapy Production Center (CTPC). This is a fast-paced lab involved in cutting edge technology, research and clinical immunotherapeutic programs. New personnel will be
-
synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and their
-
synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and their